Phospholipase Cγ1 signalling regulates lipopolysaccharide-induced cyclooxygenase-2 expression in cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 3, 2007, Pages 308-318

  Shen, E ^a,b,c   Fan, Jue ^a   Chen, Ruizhen ^c   Yee, Siu Pok ^d   Peng, Tianqing ^a,b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c FUDAN UNIVERSITY   (China)

^d LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

Cyclooxygenase 2; Gene regulation; Lipopolysaccharide; PLC 1; Signal transduction

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; CYCLOOXYGENASE 2; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE C GAMMA1; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; PHOSPHOLIPASE C GAMMA; PTGS2 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE; ADENOVIRUS; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOTE; METABOLISM; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

MUS;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HETEROZYGOTE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; PHOSPHOLIPASE C GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 34548133145     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.06.007     Document Type: Article

References (43)

1. de Gaetano G., Donati M.B., and Cerletti C. Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors. Trends Pharmacol. Sci. 24 (2003) 245-252
2. O'Banion M.K. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit. Rev. Neurobiol. 13 (1999) 45-82
3. Bolli R., Shinmura K., Tang X.L., Kodani E., Xuan Y.T., Guo Y., et al. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc. Res. 55 (2002) 506-519
4. Saito T., Rodger I.W., Hu F., Shennib H., and Giaid A. Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction. Biochem. Biophys. Res. Commun. 273 (2000) 772-775
5. Hocherl K., Dreher F., Kurtz A., and Bucher M. Cyclooxygenase-2 inhibition attenuates lipopolysaccharide-induced cardiovascular failure. Hypertension 40 (2002) 947-953
6. Grandel U., Fink L., Blum A., Heep M., Buerke M., Kraemer H.J., et al. Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation 102 (2000) 2758-2764
7. Mittra S., Hyvelin J.M., Shan Q., Tang F., and Bourreau J.P. Role of cyclooxygenase in ventricular effects of adrenomedullin: is adrenomedullin a double-edged sword in sepsis?. Am. J. Physiol.: Heart Circ. Physiol. 286 (2004) H1034-H1042
8. Tessier J.P., Thurner B., Jungling E., Luckhoff A., and Fischer Y. Impairment of glucose metabolism in hearts from rats treated with endotoxin. Cardiovasc. Res. 60 (2003) 119-130
9. Grandel U., Hopf M., Buerke M., Hattar K., Heep M., Fink L., et al. Mechanisms of cardiac depression caused by lipoteichoic acids from Staphylococcus aureus in isolated rat hearts. Circulation 112 (2005) 691-698
10. Peng T., Lu X., and Feng Q. NADH oxidase signaling induces cyclooxygenase-2 expression during lipopolysaccharide stimulation in cardiomyocytes. FASEB J. 19 (2005) 293-295
11. Monick M.M., and Hunninghake G.W. Second messenger pathways in pulmonary host defense. Annu. Rev. Physiol. 65 (2003) 643-667
12. Rebecchi M.J., and Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 80 (2000) 1291-1335
13. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70 (2001) 281-312
14. Lee S.C., Han J.S., Seo J.K., and Cha Y.N. Modulation of cyclooxygenase-2 expression by phosphatidylcholine specific phospholipase C and D in macrophages stimulated with lipopolysaccharide. Mol. Cells 15 (2003) 320-326
15. Ramana K., Willis M., White M., Horton J., DiMaio J., Srivastava D., et al. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation 114 (2006) 1838-1846
16. Ji Q.S., Winnier G.E., Niswender K.D., Horstman D., Wisdom R., Magnuson M.A., et al. Essential role of the tyrosine kinase substrate phospholipase C-g1 in mammalian growth and development. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 2999-3003
17. Peng T., Lu X., Lei M., and Feng Q. Endothelial nitric-oxide synthase enhances lipopolysaccharide-stimulated tumor necrosis factor-alpha expression via cAMP-mediated p38 MAPK pathway in cardiomyocytes. J. Biol. Chem. 278 (2003) 8099-8105
18. Peng T., Lu X., and Feng Q. Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression. Circulation 111 (2005) 1637-1644
19. Peng T., Lu X., Lei M., Moe G.W., and Feng Q. Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia. Cardiovasc. Res. 59 (2003) 893-900
20. Wen R., Chen Y., Schuman J., Fu G., Yang S., Zhang W., et al. An important role of phospholipase Cgamma1 in pre-B-cell development and allelic exclusion. EMBO J. 23 (2004) 4007-4017
21. Xie Z., Singleton P.A., Bourguignon L.Y., and Bikle D.D. Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1. Mol. Biol. Cell 16 (2005) 3236-3246
22. Wang Y., Tomar A., George S.P., and Khurana S. Obligatory role for phospholipase C-{gamma}1 in villin-induced epithelial cell migration. Am. J. Physiol.: Cell Physiol. 292 (2007) C1775-C1786
23. Puceat M., and Vassort G. Purinergic stimulation of rat cardiomyocytes induces tyrosine phosphorylation and membrane association of phospholipase C gamma: a major mechanism for InsP3 generation. Biochem. J. 318 (1996) 723-728
24. Ping P., Zhang J., Zheng Y.T., Li R.C., Dawn B., Tang X.L., et al. Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ. Res. 85 (1999) 542-550
25. Eliopoulos A.G., Dumitru C.D., Wang C.C., Cho J., and Tsichlis P.N. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J. 21 (2002) 4831-4840
26. Rosengart M.R., Arbabi S., Garcia I., and Maier R.V. Interactions of calcium/calmodulin-dependent protein kinases (CaMK) and extracellular-regulated kinase (ERK) in monocyte adherence and TNFalpha production. Shock 13 (2000) 183-189
27. Agell N., Bachs O., Rocamora N., and Villalonga P. Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin. Cell. Signal. 14 (2002) 649-654
28. Geoghegan-Morphet N.M., Lu X., Burger D., Peng T., Xu X., and Feng Q. Neuronal nitric oxidase synthase suppresses lipopolysaccharide-induced tumour necrosis factor-alpha expression in cardiomyocyte (abstract). FASEB J. 19 5, part 2 (2005) A1225
29. Sugden P.H., and Clerk A. Endothelin signalling in the cardiac myocyte and its pathophysiological relevance. Curr. Vasc. Pharmacol. 3 (2005) 343-351
30. 2+- and protein kinase C-dependent signaling pathway for nuclear factor-kappaB activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-alpha production in lipopolysaccharide-stimulated rat peritoneal macrophages. J. Biol. Chem. 281 (2006) 31337-31347
31. Leu T.H., Charoenfuprasert S., Yen C.K., Fan C.W., and Maa M.C. Lipopolysaccharide-induced c-Src expression plays a role in nitric oxide and TNFalpha secretion in macrophages. Mol. Immunol. 43 (2006) 308-316
32. Obasanjo-Blackshire K., Mesquita R., Jabr R.I., Molkentin J.D., Hart S.L., et al. Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase. Cardiovasc. Res. 71 (2006) 672-683
33. Shinmura K., Xuan Y.T., Tang X.L., Kodani E., Han H., Zhu Y., et al. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ. Res. 90 (2002) 602-608
34. Rhee S.G., and Bae Y.S. Regulation of phosphoinositide-specific phospholipase C isozymes. J. Biol. Chem. 272 (1997) 15045-15048
35. Falasca M., Logan S.K., Lehto V.P., Baccante G., Lemmon M.A., and Schlessinger J. Activation of phospholipase C gamma by PI 3-kinase induced PH domain-mediated membrane targeting. EMBO (Eur. Mol. Biol. Organ.) J. 17 (1998) 414-422
36. Rameh L.E., Rhee S.G., Spokes K., Kazlauskas A., Cantley L.C., and Cantley L.G. Phosphoinositide 3-kinase regulates phospholipase Cg-mediated calcium signaling. J. Biol. Chem. 273 (1998) 23750-23757
37. Li Z., Wahl M.I., Eguinoa A., Stephens L.R., Hawkins P.T., and Witte O.N. Phosphatidylinositol 3-kinase-gamma activates Bruton's tyrosine kinase in concert with Src family kinases. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13820-13825
38. Tsatsanis C., Androulidaki A., Venihaki M., and Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38 (2006) 1654-1661
39. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000) 145-182
40. Kirtikara K., Raghow R., Laulederkind S.J., Goorha S., Kanekura T., and Ballou L.R. Transcriptional regulation of cyclooxygenase-2 in the human microvascular endothelial cell line, HMEC-1: control by the combinatorial actions of AP2, NF-IL-6 and CRE elements. Mol. Cell. Biochem. 203 (2000) 41-51
41. Zhang Z., Sheng H., Shao J., Beauchamp R.D., and DuBois R.N. Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells. Neoplasia 2 (2000) 523-530
42. Chang Y.J., Wu M.S., Lin J.T., Sheu B.S., Muta T., Inoue H., et al. Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol. Pharmacol. 66 (2004) 1465-1477
43. Aikawa R., Komuro I., Yamazaki T., Zou Y., Kudoh S., and Tanaka M. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Invest. 100 (1997) 1813-1821